Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA011026 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA011026, RRID:AB_1850426
- Product name
- Anti-ARHGEF11
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human ARHGEF11, Gene description: Rho guanine nucleotide exchange factor (GEF) 11, Alternative Gene Names: GTRAP48, KIAA0380, PDZ-RHOGEF, Validated applications: WB, IHC, Uniprot ID: O15085, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Protumoral bone marrow-derived cells migrate via Gβγ-dependent signaling pathways and exhibit a complex repertoire of RhoGEFs
Myosin-II-mediated cell shape changes and cell intercalation contribute to primitive streak formation
Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models
Cervantes-Villagrana R, Color-Aparicio V, Reyes-Cruz G, Vázquez-Prado J
Journal of Cell Communication and Signaling 2019;13(2):179-191
Journal of Cell Communication and Signaling 2019;13(2):179-191
Myosin-II-mediated cell shape changes and cell intercalation contribute to primitive streak formation
Rozbicki E, Chuai M, Karjalainen A, Song F, Sang H, Martin R, Knölker H, MacDonald M, Weijer C
Nature Cell Biology 2015;17(4):397-408
Nature Cell Biology 2015;17(4):397-408
Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models
Härmä V, Knuuttila M, Virtanen J, Mirtti T, Kohonen P, Kovanen P, Happonen A, Kaewphan S, Ahonen I, Kallioniemi O, Grafström R, Lötjönen J, Nees M
Oncogene 2011;31(16):2075-2089
Oncogene 2011;31(16):2075-2089
No comments: Submit comment
Enhanced validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Recombinant expression validation
- Main image
- Experimental details
- Western blot analysis in control (vector only transfected HEK293T lysate) and ARHGEF11 over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells, LY404959).
- Sample type
- Human
- Protocol
- Protocol